Latest News

03.01.21

J&J’s COVID-19 Vaccine Wins FDA Authorization for Emergency Use

Source: FirstWord

02.25.21

Remembering Ophthalmic Industry Executive George Marcellino

Source: Iridex

02.25.21

Moderna’s Variant-Specific COVID-19 Vaccine Candidate Ready for Clinical Testing

Source: FirstWord

02.24.21

One-Dose J&J COVID-19 Vaccine Meets Criteria as Safe and Effective, FDA Report Finds

Source: USA Today

02.24.21

Pfizer, Moderna and J&J Tout Supercharged COVID-19 Vaccine Output, Eyeing Nearly 140 Million New Doses by March

Source: FiercePharma

02.23.21

FDA Outlines Faster Path for COVID-19 Vaccines That Tackle New Variants

Source: FirstWord

02.23.21

UK Real-World Data Show COVID-19 Vaccine Linked to Lower Infection, Hospitalization Rates

Source: FirstWord

02.22.21

Single Dose of Pfizer, BioNTech’s COVID-19 Vaccine 85% Effective: Study

Source: FirstWord

02.19.21

The Vision Council Releases Results of January 2021 Eyecare Provider Insights Survey

Source: The Vision Council

02.18.21

Pfizer’s COVID-19 Vaccine Stimulates Lower Antibody Response Against B.1.351 Strain

Source: FirstWord

View more stories